Put companies on watchlist
Davita
ISIN: US23918K1088
WKN: 897914
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Davita · ISIN: US23918K1088 · PR Newswire (ID: 20250430LA63174)
30 April 2025 05:00PM

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call


DENVER, April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: 

Monday, May 12, 2025

Starting at 5:00 p.m. EDT

Webcast can be accessed using this link 

Dial in number: 877-918-6630

International dial in: 517-308-9042

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

About DaVita Inc.

DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2024, DaVita served approximately 281,100 patients at 3,166 outpatient dialysis centers, of which 2,657 centers were located in the United States and 509 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information 

Investors:

IR@davita.com

DaVita Logo (PRNewsfoto/DaVita)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-1st-quarter-2025-investor-conference-call-302442796.html

SOURCE DaVita

Visual performance / price development - Davita
Smart analysis and research tools can be found here.
MIC: XNYS
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942